anyone else notice regulatory kicking in around week 17
Here it is: anyone else notice regulatory kicking in around week 17. One person, one log, no control group, so read it accordingly. Why identity, not purity, is the test to buy here. This is a short peptide with a published sequence. Synthesis is not difficult, which means the market is wide and the analytical…
Left up. It distinguishes rodent work from human work, which is the standard on this board.
Left up.
Disagreeing with this line: that paper is in a rodent model and it is being quoted as a human result.
That is a purity figure, not an identity confirmation. Two different tests and only one answers the question asked.
Correction: that study was in rodents. Worth stating explicitly since the thread has been reading it as clinical.
What method produced that purity number?
Is that a clinical claim or a preclinical one?
Disagree — that is a rodent study and you are stating it as a human effect. The distance between those is the entire argument.
regulatory status varies by jurisdiction and it has moved recently